Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen

Biol Blood Marrow Transplant. 2017 Feb;23(2):300-309. doi: 10.1016/j.bbmt.2016.11.009. Epub 2016 Nov 11.

Abstract

The impact of HLA mismatch in hematopoietic stem cell transplantation with reduced-intensity conditioning (RIC) has not been fully examined. We analyzed a total of 1130 cases to examine the effects of HLA allele mismatch in unrelated bone marrow transplantation (BMT) with RIC in the Japan Marrow Donor Program registry cohort. Compared with HLA 8/8-allele match (n = 720, 8/8 match), both 1 (n = 295, 7/8 match) and 2 allele mismatches (n = 115, 6/8 match) were associated with significant reduction of overall survival (OS) (hazard ratio [HR], 1.34; P = .0024 and HR, 1.33; P = .035 for 7/8 and 6/8 match, respectively). The incidence of grades 2 to 4 acute graft-versus-host disease (aGVHD) increased with increasing number of mismatched alleles (HR, 1.36 and HR, 2.08 for 7/8 and 6/8 match, respectively). Nonrelapse mortality showed a similar tendency to aGVHD (HR, 1.35 for 7/8 and HR, 1.63 for 6/8). One-allele mismatches at the HLA-A or -B and HLA-C loci were significantly associated with inferior OS compared with 8/8 match (HR, 1.64 for A or B mismatch and HR, 1.41 for C mismatch), whereas HLA-DRB1 allele mismatch was not (HR, 1.16; P = .30). However, the effect of HLA-A or -B and -C mismatch on OS was not observed in those who received RIC BMT since 2010, in contrast to recipients before 2010. These results suggested that in unrelated RIC BMT, 1-allele mismatch is associated with poorer outcome, and the impact of HLA mismatch may differ depending on the HLA locus, although these HLA mismatch effects may be different in recent cases.

Keywords: HLA mismatch; Reduced-intensity conditioning; Unrelated bone marrow transplantation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Allografts
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease / etiology
  • HLA Antigens / immunology*
  • Hematologic Neoplasms / therapy
  • Histocompatibility*
  • Humans
  • Kaplan-Meier Estimate
  • Leukocyte Count
  • Living Donors
  • Male
  • Melphalan / administration & dosage
  • Middle Aged
  • Neutrophils
  • Retrospective Studies
  • Risk
  • Transplantation Conditioning / methods*
  • Whole-Body Irradiation
  • Young Adult

Substances

  • HLA Antigens
  • Busulfan
  • Melphalan